Inadequate diabetic care: global figures cry for preventive measures and personalized treatment

Abstract

Diabetes mellitus (DM) is a lifelong progressive disease. Currently there are more than 285 million DM-affected people worldwide. Globally the prevalence of diabetes continues to rise and is more pronounced in countries with large populations such as China, India and USA. Driving forces behind the epidemic are obesity, aging of the population and longer life expency. Prospective, the majority of diabetic population will be in their six to eight decades of life with the implication of more females than males. Severe micro- and macrovascular complications associated with diabetes lead to a highly increased morbidity and mortality. Therefore, DM is projected to be one of the leading health problems of 21st centuary. Urgent measures are required to reduce the diabetic burden. Thus advanced predictive diagnostic tools and personalized treatment strategies in (pre)diabetic care are critical and should exert beneficial impact on public health.

A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control

“…In the last decades, prevalence of type 2 diabetes shows an epidemic growth [1,2]; taking into account the incidence and diabetes mortality, it is expected that total diabetes prevalence (diagnosed and undiagnosed cases) will reach 25% to 28% by 2050 [3].…”

Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

“…Single asterisks denote estimations as published around the year 2000; double asterisks denote stepwise worsening prognosis (from black circles to black diamond ) as published in 2003–2008; current prognoses are marked in red colour (adapted from [1,2]).…”

Preparation and Physico Chemical Analysis of a Herbo Mineral Compound Mehakulanthaka Rasa

“…Diabetes is one of the world's major diseases, currently affecting an estimated 285 million people worldwide 1 . Oral hypoglycemic agents form a primary part of treatment of diabetes but prominent side effects of such drugs are the main reason for a number of people seeking alternative therapies that may have less severe or no side effects.…”